8th June 2018 Content supplied by: bioMérieux (Industry)
ENDONEXT™ - The Evolution of Endotoxin Testing
- ENDONEXT™ - Endotoxin Detection Assays based on sustainable recombinant horseshoe crab Factor C (rFC), Instruments, Software and Accessories
- ENDOXPERTS™ - Feasibility studies, endotoxin method validation and protocol development services with a special focus on Low Endotoxin Recovery (LER)
bioMérieux endotoxin detection assays and services - ushering in a new era of smarter, more sustainable pharmaceutical quality control
One of our main missions is to innovate in the field of endotoxin detection, with a strong focus on patient safety. Our ENDONEXTTM Endotoxin Detection Assays based on recombinant Horseshoe Crab Factor C (rFC) give you the performance and security of supply, needed for even the most challenging quality control needs throughout your manufacturing process. Using synthetic rFC instead of blood cells from Horseshoe crabs not only ensures ecological sustainability, but also unprecedented accuracy, sensitivity, lot-to-lot consistency, and easy automation.
With our ENDOXPERTSTM Endotoxin Services we also provide routine testing and feasibility studies as well as specialized services for analytical issues such as Low Endotoxin Recovery (LER). Our work for leading pharmaceutical companies has resulted in validated methods for LER, fulfilling regulatory requirements. Applying true scientific soundness, we continue our contribution to the deepened knowledge of the LER phenomenon and complex nature of endotoxin.
Date Published: 8th June 2018
Source article link: http://go.biomerieux.com/ENDONEXT